Palisade Bio (PALI) Revenue Growth (3y) (2014 - 2023)
Palisade Bio (PALI) Revenue Growth (3y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Palisade Bio | 424.57 Mn | 291.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 246.30% |
| Dec 31, 2020 | -78.53% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 34.04% |
| Dec 31, 2019 | -34.13% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 46.71% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 365.70% |
| Mar 31, 2018 | -5.01% |
| Dec 31, 2017 | 278.24% |
| Sep 30, 2017 | -20.63% |
| Jun 30, 2017 | -20.63% |
| Mar 31, 2017 | -15.66% |
| Dec 31, 2016 | 51.81% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |